Global Cancer Diagnostics Market Size-Forecasts to 2026

As per the research conducted by GME, the Global Cancer Diagnostics Market is predicted to grow from USD 16.7 billion in 2021 to reach 25.7 billion by 2026 with a CAGR of 10.7% from 2021-2026. The cancer diagnostics market will grow rapidly mainly due to rising technological developments in early detection process, as well as increasing initiatives supported by government and global health organizations to raise cancer awareness, increasing spike in the number of private diagnostic centers, and rapidly increasing public partnerships to improve diagnostic imaging center infrastructure.

Browse 153 Market Data Tables and 115 Figures spread through 185 Pages and in-depth TOC on “Global Cancer Diagnostics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-cancer-diagnostics-market-3308

By Type (Laboratory Tests Genetic Tests, Imaging, Biopsy, Endoscopy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User (Hospitals, Diagnostic Centers), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
• During the forecast period, the imaging segment is projected to hold the largest share in the market.
• The imaging segment holds the largest share of the market in terms of revenue generation from 2021-2026
• As the number of COVID-19 cases increased, the healthcare system turned its priority to containing the disease, delaying the identification and treatment of other chronic disorders such as cancer.
• During the forecast period, the breast cancer segment is expected to dominate the market.
• BIO SB, Fujifilm Corporation, Abbott, Becton, Dickinson and Company, Quidel Corporation, Cancer Diagnostics, Inc., Bio-Rad Laboratories, Tzar Labs, Biomerieux, Diasorin SpA, Siemens Healthineers, GE Healthcare, Janssen Diagnostic LLC, Sysmex Corporation among others, are the major vendors competing in the Cancer Diagnostics market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-cancer-diagnostics-market-3308

Type Outlook (Revenue, USD Billion, 2021-2026)
• Laboratory Tests
• Genetic Tests
• Imaging
• Biopsy
• Endoscopy
• Others

End-User Outlook (Revenue, USD Billion, 2021-2026)
• Hospitals
• Diagnostic Centers

Application Outlook (Revenue, USD Billion, 2021-2026)
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Lung Cancer
• Prostate Cancer
• Skin Cancer
• Blood Cancer
• Kidney Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Others

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Tracy Simon
Email address: [email protected]
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php